GT Biopharma, Inc. — Director's Dealing 2011

Jan 20, 2011

SEC Form 3/A — Form 3/A

Issuer: OXIS INTERNATIONAL INC (OXIS.OB)
CIK: 0000109657
Period of Report: 2009-10-13

Reporting Person: Theorem Group, LLC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Warrant	$0.0625	2014-09-30	Common Stock (900000)		Direct
Series B Warrant	$0.075	2014-09-30	Common Stock (900000)		Direct

Footnotes

F1: The number of shares was erroneously reported in the reporting person's original Form 3.